Cargando…
Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer
Autores principales: | Bhamidipati, Deepak, Subbiah, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266487/ https://www.ncbi.nlm.nih.gov/pubmed/37324544 http://dx.doi.org/10.18632/oncoscience.579 |
Ejemplares similares
-
Lurbinectedin for small cell lung cancer
Publicado: (2021) -
Lurbinectedin in small cell lung cancer
por: Manzo, Anna, et al.
Publicado: (2022) -
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020) -
Lurbinectedin-induced thrombocytopenia: the role of body surface area
por: Papachristos, Apostolos, et al.
Publicado: (2022) -
What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020)